John Bencich

This profile gathers the share dealings of John Bencich across 2 companies, led by Achieve Life Sciences, Inc. and AEON Biopharma, Inc. The record holds 14 filings, for trades running from 27 May 2021 to 2 April 2026.

Every open-market trade on record is a purchase: 4 purchases worth €102k, and no sale. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants and 5 option exercises.

In size, the median ticket on the buying side is €34k. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The record was last updated on 3 April 2026 with a share grant in AEON Biopharma, Inc. The latest purchase dates back some time: it was published 956 days ago, on 6 March 2024. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.